Skip to main content
PHARMARESEARCH BIO Co., Ltd. logo

PHARMARESEARCH BIO Co., Ltd. — Investor Relations & Filings

Ticker · 217950 ISIN · KR7217950005 KO Manufacturing
Filings indexed 162 across all filing types
Latest filing 2025-06-20 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 217950

About PHARMARESEARCH BIO Co., Ltd.

http://www.pr-bio.co.kr/eng/

PHARMARESEARCH BIO Co., Ltd. is a biopharmaceutical company specializing in regenerative medicine. The company leverages marine biotechnology to research, develop, and produce innovative biological products aimed at enhancing human health. Its core activities center on the development of raw materials for cell and tissue regeneration, such as Polydeoxyribonucleotide (PDRN) and Polynucleotide (PN) derived from salmon DNA. The company's research and development pipeline also includes other biological products, such as toxin-based therapeutics, to address various medical and aesthetic needs.

Recent filings

Filing Released Lang Actions
전환청구권행사 (제3회차)
Share Issue/Capital Change Classification · 100% confidence The document is a formal notification regarding the exercise of conversion rights (전환청구권 행사) for convertible bonds (전환사채). It details the number of shares issued, the conversion price, and the impact on the company's capital structure. This type of filing relates to changes in share capital resulting from the conversion of debt instruments, which falls under the 'Share Issue/Capital Change' category.
2025-06-20 Korean
기업설명회(IR)개최결과
Report Publication Announcement Classification · 100% confidence The document is a formal notification regarding the results of an Investor Relations (IR) meeting held by PharmaResearchBio. It lists the date, location, attendees, and agenda items of the meeting. Since it is a short regulatory announcement confirming that an IR event took place and where the materials can be found, it fits the definition of a Regulatory Filing (RNS) or a general announcement of corporate activity that does not constitute the full presentation itself.
2025-04-30 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회 개최). It provides details such as the date, time, location, target audience, and purpose of the meeting. Since this is a notification of an event rather than the presentation materials themselves, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2025-04-23 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회 결과' (Annual General Meeting Results) and details the outcomes of the shareholder meeting held on 2025-03-25, including the approval of financial statements, election of directors, and remuneration limits. This matches the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA).
2025-03-25 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal announcement titled '감사보고서 제출' (Submission of Audit Report) for PharmaResearchBio. It provides a summary of the audit opinion (unqualified/appropriate), key financial figures (assets, liabilities, revenue, profit), and the name of the accounting firm. While it contains financial data, it is a regulatory disclosure announcing the completion and submission of the audit report rather than the full annual report or a standalone audit document. Following the 'Menu vs Meal' rule, this is a notification of the report's submission. FY 2024
2025-03-17 Korean
사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is titled '사업보고서' (Business Report) and covers the fiscal period from 2024.01.01 to 2024.12.31. It contains comprehensive company information, including financial data, management reports, and operational details, which is characteristic of an Annual Report (10-K equivalent in the Korean regulatory context). It is not a short announcement or a certification, but the full report itself. FY 2024
2025-03-17 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.